We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Grey Wolf Animal Health Corp | TSXV:WOLF | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.03 | 2.68% | 1.15 | 1.14 | 1.15 | 1.15 | 1.14 | 1.14 | 10,600 | 20:28:41 |
TORONTO, June 22, 2023 /CNW/ - Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, announced today the voting results from the Company's annual and special meeting of the shareholders held on June 21, 2023 (the "Meeting").
The results of the director elections are as follows:
Director Nominee | Outcome | Votes For | % For | Votes Withheld | % Withheld |
Jill Angevine | Elected | 9,409,968 | 99.894 | 10,000 | 0.106 |
Shawn Aspden | Elected | 9,409,968 | 96.072 | 370,000 | 3.928 |
Diane Bourassa | Elected | 9,409,968 | 99.894 | 10,000 | 0.106 |
Robert Harris | Elected | 9,409,968 | 99.894 | 10,000 | 0.106 |
Dr. Ian Sandler | Elected | 9,409,968 | 99.894 | 10,000 | 0.106 |
The shareholders of the Company also voted: (i) to re-appoint PricewaterhouseCoopers LLP, as auditors of the Company for the ensuing year and to authorize the directors to determine their remuneration, (ii) to approve the Company's amended and restated stock option plan in the form attached as Schedule "A" to the management information circular dated May 9, 2023 prepared in connection with the Meeting (the "Information Circular"), and (iii) to approve the Company's Advance Notice By-law in the form attached as Schedule "B" to the Information Circular.
Grey Wolf Animal Health Corp., headquartered in Toronto, Canada, is a diversified animal health company founded by a veterinarian to bring to market a broad portfolio of products that meets the unmet needs of veterinarians, clinics and pets. The Company's strategy is to in-license, acquire or develop innovative prescription and non-prescription products for commercialization in the veterinarian channel in Canada. For additional information, please visit: www.greywolfah.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
SOURCE Grey Wolf Animal Health Corp.
Copyright 2023 Canada NewsWire
1 Year Grey Wolf Animal Health Chart |
1 Month Grey Wolf Animal Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions